产品详情 |
Edit |   |
Antigenic Specificity | CD150 (SLAM) |
Clone | TC15-12F12.2 |
Host Species | Rat |
Reactive Species | mouse |
Isotype | IgG2a, λ |
Format | TotalSeq™-A oligomer conjugate |
Size | 10 µg |
Concentration | n/a |
Applications | Proteogenomics. TotalSeq™ reagents are designed to profile protein expression at a single cell level following an optimized protocol similar to the CITE-seq workflow. |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | TotalSeq™-A0203 anti-mouse CD150 (SLAM). CD150 is a 75-95 kD member of the immunoglobulin superfamily, also known as SLAM (signaling lymphocyte activation molecule) or IPO-3. CD150, a single chain type I transmembrane molecule, is expressed on thymocytes, T cell subsets, B cells, dendritic cells, and endothelial cells. The expression is upregulated upon activation. CD150 expression has been shown to be maintained on Th1 but not Th2 clones. T regulatory cells express a relatively high level of CD150. Antibodies against CD150 have been shown to augment IFN-γ production by Th1 cells, especially when co-stimulated through the TCR. CD150 associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, and this association is thought to be involved in signal transduction. In combination with CD48, CD150 is a useful marker for hematopoietic stem cell studies. |
Immunogen | Mouse SLAM-human IgG1 fusion protein |
Other Names | SLAM, IPO-3, Signaling Lymphocyte Activation Molecule |
Gene, Accession # | Gene ID: 27218 |
Catalog # | 115945 |
Price | |
Order / More Info | CD150 (SLAM) Antibody from BIOLEGEND |
Product Specific References | n/a |
产品资料 |
|
|